Influence of reduced glutathione combined with Danshen powder injection on acute pancreatitis / 中国医师进修杂志

Objective To study the diagnostic value of reduced glutathione combined with Danshen powder injection on acute pancreatitis.Methods A total of 180 cases with acute pancreatitis were allocated into three groups:treatment group,control group 1 and control group 2 by random digits table method with 60 cases each.The relief time of abdominal pain,the duration of serum/urine amylase recovery,the duration of liver function damage recovery and the hospital stay time was compared.Results After the treatment,patients in treatment group showed better improvement in clinical symptom.The relief time of abdominal pain,the duration of serum/urine amylase recovery,the duration of liver function damage recovery and the hospital stay time in treatment group was shorter than that in control group 1 and control group 2[(2.9 ± 1.3) d vs.(4.1 ± 1.9),(4.5 ±2.3) d; (3.4± 1.2) dvs.(4.0±2.7),(3.9±2.1) d;(4.9± 2.1) d vs.(5.8±2.5),(6.1 ± 1.3)d; (6.7 ± 2.2)d vs.(8.6 ± 4.1),(9.5 ± 2.8)d; (8.1 ± 2.8)d vs.(9.8 ± 2.7),(10.3 ± 3.6) d],and there was significant difference (P ＜0.05).The total effective rate in treatment group was 96.7％ (58/60),which was higher than that in control group 1 and control group 2 [86.7 ％(52/60),83.3 ％ (50/60)],and there was significant difference (P ＜ 0.05).Conclusion Reduced glutathione combined with Danshen powder injection for acute pancreatitis can greatly decrease the serum inflammatory factors and improve the clinical efficacy.

Bone metastasis from ovarian cancer. Clinical analysis of 26 cases

To study the clinical characteristics of bone metastasis from ovarian cancer, and facilitate physicians to develop treatment strategies. This retrospective study was carried out in the Provincial Hospital Affiliated to Shandong University, Shandong, China. Twenty-six cases of bone metastasis from ovarian cancer treated between January 2002 and May 2008 were reviewed, and the clinical data were collected. In the current study, the incidence of bone metastasis is 0.82%. Twelve cases of bone metastasis occurred in the cervical vertebra, 10 in the lumbar vertebra, 8 in the pelvis, 7 in the thoracic vertebra, 5 in the limbs, one in the ribs, and 2 in the sternum. Lung metastasis occurred concomitantly in 9 cases, liver metastasis in 5 cases, brain metastasis in 4 cases, splenic metastasis in 3 cases, adrenal metastasis in 2 cases, and lymphatic metastasis in 12 cases. Twenty-three cases [88.5%] of bone metastasis were detected in stage 3-4, and 3 [11.5%] in stage 2 [p=0.000]. The survival time in cases treated using comprehensive therapy was longer than those using radiotherapy or chemotherapy alone [p=0.047]. Bone metastasis from ovarian cancer is rare, however, the increasing pathological stage of ovarian cancer may add to the risk of bone metastasis, especially in the cases with lung or lymphatic metastasis. The pelvis and vertebral bone are the most common location of bone metastasis, and comprehensive treatment may improve the survival time of patients

Clinical features of invasive pneumococcal disease and its antimicrobial resistance among children under the age of 5 years / 中国小儿急救医学

Objective To investigate the clinical characteristics of invasive pneumococcal disease (IPD) and its drug resistance among children under the age of 5 years.Methods Clinical characteristics of 45 children of IPD admitted to the Shengjing Hospital of China Medical University from 2009 to 2010 and antimicrobial non-susceptibility results were analyzed retrospectively.Results Forty-five cases of IPD were confirmed by positive culture of sterile body site,most of which occurred between April and June.Most of the IPD children were below the age of 2 years,which accounted for 66.7％ (30/45).The disease spectrum included bacteremia in 32 cases (71.1％),encephalitis in 9 cases (20.0％),empyema in 23 cases (51.1％),necrotizing pneumonia in 10 cases (22.2％).Pneumococcal non-susceptibility to erythromycin were found to be 100％,to clindamycin were 95％,to tetracycline were 95.12 ％,to trimethoprim-sulfamethoxaole were 80.49％,to chloramphenicol were 18.18％,while pneumococcal resisitanse to rifampicin,quinolones and vancomycin were 0.Eight of eleven and 18/24 were found to be pneumoccal resistance to penicillin and cephalosporin respectively and their minimum inhibitory concentrations were high.Twenty five cases were cured (55.6％).Fifteen cases were improved (33.3％).Four cases died (8.9％).One cases was retreated.All cases of death were under the age of 2 years.Conclusion IPD is more common with a high mortality rate among those under the ages of 2 years.Poor outcome is associated with Streptococcus pneumoniae resistance to antibiotics.

Changes in drug resistance and distribution of Streptococcus pneumonia infection from 2001 to 2011 in Shenyang area / 中国小儿急救医学

Objective To investigate the dynamic changes of infectious distribution,current resistant situation of Streptococcus pneumoniae(SP) and resistant to penicillin and other 10 kinds of antibiotics for the guidance of clinical therapy of SP.Methods Bacteria were identified by French BioMerieux API identification system,VITEK 2-COMPACT identification system and Optochin test,bile solubility test.In vitro,drug susceptibility test to penicillin,cefotaxime,and other 10 kinds of antibiotics were conducted with K-B disk diffusion method combined with the concentration gradient method.Drug susceptibility results were analyzed from 2001 to 2011.Results In recent 11 years,SP antimicrobial resistance rate had increased year after year,especially rates of penicillin-resistant and penicillin not-sensitive had increased significantly,rising from 8.3％( in 2001 ) to 72.7％ ( in 2011 ) ( meningitis 86.4％,non-meningitis 59.0％ ).Resistance rate of cefotaxime,belonging to third-generation cephalosporin had already accounted for 54.0％ ( meningitis 64.0％,non-meningitis 44.0％ ) ;and the resistance rate of macrolide antimicrobial was 100％ ; vancomycin-resistant strains and linezolid-resistant strains had not been detected.Conclusion Penicillin non-susceptible SP has accounted for a high percentage,antimicrobial resistance of Streptococcus pneumoniae penicillin,cephalosporins,macrolides are in serious condition.Vancomycin and linezolid should be preferred or the right antibiotics be chosen according to vitro susceptibility results of isolates in clinical treatment of severe infections caused by SP.

Changes in Drug Resistance and Distribution of Pseudomonas aeruginosa for 1999 to 2007 / 中华医院感染学杂志

OBJECTIVE To study the changes in drug resistance and distribution of Pseudomonas aeruginosa to guide drug treatment in clinic.METHODS P.aeruginosa was identified by API and VITEK2 system,and its antimicrobial ressistance was determined by Kirby-Bauer method.The antimicrobial ressistance rates were analyzed by WHONET 5.4 software.RESULTS The resistance of P.aeruginosa to 12 antibiotics was increased in the past nine years.The resistant rate to meropemem,imipenem,ciprofloxacin and ceftazidime was below 30%.Among 2127 strains of P.aeruginosa,94 strains were identified multi-drug resistant and found more frequently in ICU,and Respiratory Department.CONCLUSIONS P.aeruginosa is resistant to many kinds of antimicrobial agents,and resistant rate is increasing year by year.In order to control and slow down the occurrence of the resistant strains,it should be more careful to choose antimicrobial agents according to the antimicrobial susceptibility test.